Finance
Pharmacy company reports increased revenues for the year
Published in Cancer Weekly, July 13th, 2004
For the year ended March 31, 2004, revenues were $2,416,000, as compared to $1,609,000 for the year ended March 31, 2003.
The increase was primarily attributable to revenues from research and testing agreements. Loss from operations for the year ended March 31, 2004, was $12,866,000, as compared to a loss from operations of $4,693,000 for the year ended March 31, 2003. The loss was largely due to noncash compensation expense recorded related to the vesting of common stock, options, and warrants issued during the year, which was approximately...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2004-07-13)
More Articles from Cancer Weekly
- Cancer Risk Factor
Exposures to magnetic fields heighten a woman's risk for breast cancer - Diagnostics
Prostate specific antigen ratios offer a better way to detect prostate cancer - Gastroenterology
Intravenous morphine improves MR cholangiopancreatography image quality - Head and Neck Cancer
Autofluorescent endoscopy reveals precancerous conditions in the larynx - Acute Leukemia
Arsenic trioxide can help patients with advanced acute promyelocytic leukemia - Acute Leukemia
Fatal intracranial hemorrhage can occur in acute leukemia patients - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
